Benjamin L. Mitlyng
Expertise in
6
conditions

Dr. Benjamin L. Mitlyng

Gastroenterology
MNGI Digestive Health - Plymouth
15700 37th Avenue North, Suite 300, 
Plymouth, MN 
Accepting New Patients
Offers Telehealth
Expertise in
6
conditions
MNGI Digestive Health - Plymouth
15700 37th Avenue North, Suite 300, 
Plymouth, MN 

Overview

My clinical and research experience focused on diseases of the esophagus as well as liver cancer. I recently completed my gastroenterology fellowship at the University of Minnesota. Dr. Mitlyng joined Minnesota Gastroenterology in 2011.

Dr. Mitlyng is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Eosinophilic Esophagitis, Barrett Esophagus, Esophagitis, Endoscopy, and Gastrectomy.

Dr. Mitlyng is board certified in American Board Of Internal Medicine,2011 and Gastroenterology. He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 4 clinical trials. Dr. Mitlyng is currently accepting new patients.

Specialties

Gastroenterology

Board Certifications

American Board Of Internal Medicine,2011
Gastroenterology

Hospital Affiliations

Mercy Hospital
North Memorial Health Hospital
Maple Grove Hospital
M Health Fairview Southdale Hospital
Abbott Northwestern Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Hawaii Medical Assurance Association
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

MNGI Digestive Health - Plymouth
15700 37th Avenue North, Suite 300, Plymouth, MN 55446

Additional Areas of Focus

Dr. Mitlyng has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Endoscopy
Liver Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Enrollment Status: Terminated
Publish Date: February 19, 2025
Intervention Type: Drug
Study Drug: Budesonide oral suspension
Study Phase: Phase 3
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Multi-center, Randomized, Double Blind, Parallel-arm, Placebo Controlled Trial of Mepolizumab for Treatment of Adults and Adolescents With Active Eosinophilic Esophagitis and Dysphagia-predominant Symptoms
A Multi-center, Randomized, Double Blind, Parallel-arm, Placebo Controlled Trial of Mepolizumab for Treatment of Adults and Adolescents With Active Eosinophilic Esophagitis and Dysphagia-predominant Symptoms
Enrollment Status: Completed
Publish Date: August 23, 2023
Intervention Type: Drug, Other
Study Drug: Mepolizumab
Study Phase: Phase 2
View 3 Less Clinical Trials

6 Total Publications

Mepolizumab Improves Histologic Severity as Measured by the EoEHSS in Adolescents and Adults With Eosinophilic Oesophagitis in a Multicenter, Randomised, Double-Blind, Placebo-Controlled Clinical Trial.
Mepolizumab Improves Histologic Severity as Measured by the EoEHSS in Adolescents and Adults With Eosinophilic Oesophagitis in a Multicenter, Randomised, Double-Blind, Placebo-Controlled Clinical Trial.
Journal: Alimentary pharmacology & therapeutics
Published: March 03, 2025
Similar Doctors
Expertise in
25
conditions
Dr. Martin L. Freeman
Gastroenterology
Expertise in
25
conditions
Dr. Martin L. Freeman
Gastroenterology
Referral may be required

M Health Fairview Pancreas And Biliary Clinic Minneapolis

909 Fulton Street Southeast, Floor 4, 
Minneapolis, MN 
 (13.3 miles away)
612-624-9709
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Martin Freeman is a Gastroenterologist practicing medicine in Minneapolis, Minnesota. Dr. Freeman is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Hereditary Pancreatitis, Acute Pancreatitis, Pancreatectomy, and Islet Cell Transplantation. Dr. Freeman is board certified in Gastroenterology: American Board Of Internal Medicine, 1987 and Internal Medicine: American Board Of Internal Medicine, 1983. Dr. Freeman is currently accepting new patients.

Expertise in
25
conditions
Dr. Guru V. Trikudanathan
Gastroenterology
Expertise in
25
conditions
Dr. Guru V. Trikudanathan
Gastroenterology
Referral may be required

M Health Fairview Pancreas And Biliary Clinic Minneapolis

909 Fulton Street Southeast, Floor 4, 
Minneapolis, MN 
 (13.3 miles away)
612-624-9709
Experience:
18+ years
Languages Spoken:
English, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Guru Trikudanathan is a Gastroenterologist practicing medicine in Minneapolis, Minnesota. He has been practicing medicine for over 18 years. Dr. Trikudanathan is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Acute Pancreatitis, Chronic Pancreatitis, Pancreatectomy, and Islet Cell Transplantation. Dr. Trikudanathan is currently accepting new patients.

Expertise in
12
conditions
Dr. Aasma P. Shaukat
Gastroenterology
Expertise in
12
conditions
Dr. Aasma P. Shaukat
Gastroenterology
Referral may be required

Minneapolis Veterans Administration Hospital

1 Veterans Dr, 
Minneapolis, MN 
 (16.9 miles away)
612-467-2000
Languages Spoken:
English
See accepted insurances

Aasma Shaukat is a Gastroenterologist practicing medicine in Minneapolis, Minnesota. Dr. Shaukat is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Colorectal Polyps, Juvenile Polyposis Syndrome, Colonoscopy, and Endoscopy.

Frequently Asked Questions about Dr. Benjamin L. Mitlyng

How do I make an appointment with Dr. Benjamin L. Mitlyng?

You can book an appointment with Dr. Benjamin L. Mitlyng by calling their office at 612-871-1145. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Benjamin L. Mitlyng a top-rated expert for Eosinophilic Esophagitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Benjamin L. Mitlyng is classified as an Distinguished expert for Eosinophilic Esophagitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Benjamin L. Mitlyng specialize in?

While Dr. Benjamin L. Mitlyng is a Gastroenterology, they have specific expertise in Eosinophilic Esophagitis, Barrett Esophagus, and Esophagitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Benjamin L. Mitlyng participate in research or clinical trials?

Yes. Dr. Benjamin L. Mitlyng has published 6 articles and abstracts on conditions like Eosinophilic Esophagitis. You can view a list of Dr. Benjamin L. Mitlyng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Benjamin L. Mitlyng accept my insurance?

Dr. Benjamin L. Mitlyng accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 612-871-1145 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mitlyng's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile